Glipide Tablet 4 mg (Glymepiride)
Glimepiride 4mg
Tablet · Prescription medication
Hubist Pharmaceuticals Co., Ltd.
MFDS item code 201905559 · Approved 2019.08.07
This product's status changed to Expired on 2024.08.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to enhance blood glucose control in patients with type 2 diabetes by supplementing dietary therapy and exercise therapy. It can be used alone, but when blood glucose control is insufficient, it can be administered in combination with oral hypoglycemic agents or insulin. Furthermore, in cases where blood glucose control is inadequate with sulfonylureas or metformin monotherapy, it is used in conjunction with metformin. This helps effectively manage blood glucose through various methods and improves the patients' health.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses above 4 mg, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the amount of this medicine required may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, initiate treatment with 1 mg per day and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be considered. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. Generally, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and is used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal; initiate insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses need to be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glyburide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in insulin-dependent diabetes patients or patients with diabetic ketoacidosis or coma. Additionally, patients allergic to this medication or its components, including sulfonylureas, should not be administered this drug. There is no experience using this medication in patients with severe liver or kidney dysfunction; therefore, switching to insulin therapy is recommended. Pregnant women, women who may become pregnant, and nursing mothers should not take this medication. Patients with severe infections or those undergoing surgery, or those with severe trauma may require insulin therapy. Caution should be exercised in cases of gastrointestinal disturbances such as diarrhea or vomiting that impair food absorption due to the risk of hypoglycemia. Patients with lactose intolerance or certain genetic digestive disorders should also not take this medication. During the first week of treatment, the risk of hypoglycemia is higher, so blood glucose should be closely monitored. Particularly among the elderly, or those in poor nutritional status or who skip meals, or those in case exercise and diet are not balanced, the risk of hypoglycemia is even greater. Patients who frequently consume alcohol or have weakened liver or kidney functions also need to be cautious. Additionally, in cases of endocrine diseases such as thyroid or pituitary abnormalities, the risk of hypoglycemia may increase. If this medication is overdosed or taken with other medications, blood glucose changes may occur, so consultation with a doctor is necessary. This medication may cause hypoglycemic symptoms, including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and reduced consciousness. Severe cases may result in coma or seizures, necessitating immediate treatment. Additionally, temporary blurred vision, gastrointestinal discomfort, liver function abnormalities, blood abnormalities, and allergic reactions have been reported. If allergic symptoms such as skin rash or difficulty breathing occur, contact a physician immediately. This medication must be combined with dietary therapy and exercise therapy for blood glucose control, and it is important to take it regularly. In cases of hypoglycemia, sugars should be rapidly consumed, and artificial sweeteners are ineffective, so caution is required. During treatment, regular blood glucose and urine tests should be conducted to verify the drug's effectiveness, and if conditions change, consulting a physician is advised. When used in combination with other drugs, it can affect blood glucose control due to interactions, so all medications being taken must be disclosed. Caution is particularly needed when used with beta-blockers, antibiotics, anticoagulants, and steroids. Pregnant or nursing women should switch to insulin therapy instead of this medication as it may affect the fetus or newborn. In cases of overdose, hypoglycemia can worsen, necessitating immediate emergency treatment, including inducing vomiting, administering activated charcoal, or glucose infusion. This medication’s safety and effectiveness are not established for children, and in elderly patients, dosage adjustments should be made considering reduced kidney function. Finally, this medication should be stored out of the reach of children, and it should be kept in its original container to prevent quality deterioration.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language impairment, aphasia, visual disturbances, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from exposure to air and moisture, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy and prevents degradation.
Light blue rectangular tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride 4mg
Tablet · Prescription medication
Hubist Pharmaceuticals Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.